Short Interest in Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) Decreases By 20.5%

Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE – Get Free Report) was the target of a large decrease in short interest in December. As of December 15th, there was short interest totalling 2,360,000 shares, a decrease of 20.5% from the November 30th total of 2,970,000 shares. Currently, 7.5% of the company’s stock are sold short. Based on […]

Related Keywords

Arizona ,United States ,Montreal ,Quebec ,Canada , ,Nasdaq ,Jpmorgan Chase Co ,Monte Rosa Therapeutics Inc ,Monte Rosa Therapeutics Company Profile ,Monte Rosa Therapeutics ,Get Free Report ,Rosa Therapeutics ,Point Capital Management ,Montreal Can ,Arizona State Retirement System ,Monte Rosa Therapeutics Daily ,Nasdaq Glue ,Glue ,Medical ,Stocks ,Options ,Put ,Call ,